THE CONSERVED MEMBRANE-PROXIMAL REGION OF AN INTEGRIN CYTOPLASMIC DOMAIN SPECIFIES LIGAND-BINDING AFFINITY

被引:165
作者
HUGHES, PE
OTOOLE, TE
YLANNE, J
SHATTIL, SJ
GINSBERG, MH
机构
[1] SCRIPPS RES INST, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
[2] UNIV HELSINKI, DEPT BIOCHEM, SF-00170 HELSINKI, FINLAND
[3] UNIV PENN, SCH MED, DEPT CELL & DEV BIOL, PHILADELPHIA, PA 19104 USA
[4] UNIV PENN, SCH MED, DEPT MED, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1074/jbc.270.21.12411
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integrin affinities for ligands can change markedly via a process termed inside-out signaling. We expressed several truncations of the beta(3) cytoplasmic domain in conjunction with an ''activating'' alpha subunit chimera, alpha(IIb)alpha(6B). Deletion of the 4 C-terminal residues of the beta(3) tail blocked inside-out signaling as assessed by the binding of an activation specific antibody, PAC1. Several additional truncations remained in the low affinity state, but complete truncation (beta(3) Delta 717) caused PAC1 binding, Activation by this truncation mutant did not depend on the cr subunit cytoplasmic domain and was resistant to inhibitors of cellular metabolism and the over-expression of an isolated beta(3) cytoplasmic domain. Since deletion of beta 3(Leu(717)-Asp(723)) results in a constitutively activated integrin, this membrane-proximal seven amino acids of the beta(3) cytoplasmic domain is required to maintain alpha(IIb)beta(3) in a default low affinity state. The amino acid sequence of this region is conserved among integrins. Moreover, the conserved membrane-proximal sequence in alpha subunit tails seems to serve a similar function. Consequently, the conserved membrane-proximal regions of both integrin cytoplasmic domains control the ligand binding affinity of the extracellular domain.
引用
收藏
页码:12411 / 12417
页数:7
相关论文
共 62 条
  • [1] LOW-MOLECULAR-WEIGHT, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS
    ALIG, L
    EDENHOFER, A
    HADVARY, P
    HURZELER, M
    KNOPP, D
    MULLER, M
    STEINER, B
    TRZECIAK, A
    WELLER, T
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) : 4393 - 4407
  • [2] ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
  • [3] BAJT ML, 1994, J BIOL CHEM, V269, P20913
  • [4] BENNETT JS, 1993, J BIOL CHEM, V268, P3580
  • [5] INHIBITION OF FIBRINOGEN BINDING TO STIMULATED HUMAN-PLATELETS BY A MONOCLONAL-ANTIBODY
    BENNETT, JS
    HOXIE, JA
    LEITMAN, SF
    VILAIRE, G
    CINES, DB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09): : 2417 - 2421
  • [6] BENNETT JS, 1988, J BIOL CHEM, V263, P12948
  • [7] EXPOSURE OF PLATELET FIBRINOGEN RECEPTORS BY ADP AND EPINEPHRINE
    BENNETT, JS
    VILAIRE, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05) : 1393 - 1401
  • [8] INTEGRIN (THE CSAT ANTIGEN) - FUNCTIONALITY REQUIRES OLIGOMERIC INTEGRITY
    BUCK, CA
    SHEA, E
    DUGGAN, K
    HORWITZ, AF
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 103 (06) : 2421 - 2428
  • [9] CHEN YP, 1994, BLOOD, V84, P1857
  • [10] SER-752-]PRO MUTATION IN THE CYTOPLASMIC DOMAIN OF INTEGRIN-BETA-3 SUBUNIT AND DEFECTIVE ACTIVATION OF PLATELET INTEGRIN-ALPHA-IIB-BETA-3 (GLYCOPROTEIN-IIB-IIIA) IN A VARIANT OF GLANZMANN THROMBASTHENIA
    CHEN, YP
    DJAFFAR, I
    PIDARD, D
    STEINER, B
    CIEUTAT, AM
    CAEN, JP
    ROSA, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10169 - 10173